Medicus Pharma Ltd 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Medicus Pharma Ltd 's ROA in the second quarter of 2026?
Medicus Pharma Ltd recorded a cumulative net loss of $-45 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -328.99%.

However, within the Healthcare sector 893 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4601, from total ROA ranking in the first quarter of 2026 at 5316.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	127.21 %	31.27 %	78.18 %	95.15 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-45	-39	-35	-31	-17
Return On Assets (TTM)	-328.99 %	-399.83 %	-376.75 %	-370.85 %	-241.16 %
MDCX's Total Ranking	# 4601	# 5316	#	#	#
Total Assets (TTM) in million	27	7	10	10	12
Seq. Total Assets Change	265.11 %	-26.18 %	0.84 %	-16.4 %	110.94 %
Seq. Net Income Change	-	-	-	-	-

MDCX's 5 Years Annual ROA >> Back to MDCX Management Effectiveness >> Compare MDCX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 427
Sector	# 894
Overall	# 4523

Return On Assets Statistics
High	Average	Low
-328.99 %	-368.53 %	-399.83 %
(Jun 30 2026)		(Mar 31 2026)

Financial Statements
Medicus Pharma Ltd 's Assets	$ 27 million	MDCX's Balance sheet
Medicus Pharma Ltd 's Income	$ -12 million	Quarterly MDCX's Income Statement
MDCX's Income by Division		See MDCX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	FY	FY	FY
Y / Y Total Assets Change	78.18 %	-	-	-	-
Total Assets in million	10	6	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-35	-11	0	0	0
Annual Return On Assets	-352.28 %	-197.55 %	-	-	-

MDCX's 5 Years Annual ROA >> Back to MDCX Management Effectiveness >> Compare MDCX ROA to its Competitors

More Return On Assets Ratios
MDCX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MDCX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MDCX's Competitors
Subscribers only: Roa for Medicus Pharma Ltd 's Suppliers
Subscribers only: Return On Assets for MDCX's Customers

You may also want to know
MDCX's Roi	MDCX's Inventory Turnover Ratio	MDCX's Growth Rates	MDCX's Dividend Comparisons
	MDCX's Profitability Ratios	MDCX's Asset Turnover Ratio	MDCX's Dividend Growth
MDCX's Roe	MDCX's Valuation Ratios	MDCX's Financial Strength Ratios	MDCX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:27:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.